Knowledge that people with intellectual disabilities have of their inhaled asthma medications: messages for pharmacists

Davis, Sharon; Durvasula, Seeta; Merhi, Diana; Young, Paul M.; Traini, Daniela; Anticevich, S. Z.

doi:10.1007/s11096-015-0217-x

Cited by 15 publications

(55 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…5 Although published research to date has focused on people with a wide range of severity for ID, restrictions by small samples, short follow-up periods and limited sample representativeness existed. [19][20][21][22][23] Specifically, an elevated risk of mortality from bronchopneumonia of around 6.5-fold was reported in a cohort with moderate to severe ID in the UK, 21 and respiratory infection was found the most common cause of death over a 1-year period in a UK cohort of adults with ID receiving mealtime support for any eating, drinking or swallowing problem. 20 In a Taiwanese institutional sample of people with ID followed for up to 4 years, pneumonia was the topmost reason for hospitalisation.…”

Section: Introductionmentioning

confidence: 99%

Hospital admissions for respiratory system diseases in adults with intellectual disabilities in Southeast London: a register-based cohort study

et al. 2017

View full text Add to dashboard Cite

BackgroundIntellectual disability (ID) carries a high impact on need for care, health status and premature mortality. Respiratory system diseases contribute a major part of mortality among people with ID, but remain underinvestigated as consequent morbidities.MethodsAnonymised electronic mental health records from the South London and Maudsley Trust (SLaM) were linked to national acute medical care data. Using retrospective cohort and matched case–control study designs, adults with ID receiving SLaM care between 1 January 2008 and 31 March 2013 were identified and compared with local catchment residents for respiratory system disease admissions. Standardised admission ratios (SARs) were first calculated, followed by a comparison of duration of hospitalisation with respiratory system disease between people with ID and age-matched and gender-matched random counterparts modelled using linear regression. Finally, the risk of readmission for respiratory system disease was analysed using the Cox models.ResultsFor the 3138 adults with ID identified in SLaM, the SAR for respiratory system disease admissions was 4.02 (95% CI 3.79 to 4.26). Compared with adults without ID, duration of hospitalisation was significantly longer by 2.34 days (95% CI 0.03 to 4.64) and respiratory system disease readmission was significantly elevated (HR=1.35; 95% CI 1.17 to 1.56) after confounding adjustment.ConclusionsRespiratory system disease admissions in adults with ID are more frequent, of longer duration and have a higher likelihood of recurring. Development and evaluation of potential interventions to the preventable causes of respiratory diseases should be prioritised.

show abstract

Section: Introductionmentioning

confidence: 99%

Hospital admissions for respiratory system diseases in adults with intellectual disabilities in Southeast London: a register-based cohort study

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Characteristics of the included articles are summarized in Table 2 Australia (Davis et al, 2016(Davis et al, , 2014. Characteristics of the included articles are summarized in Table 2 Australia (Davis et al, 2016(Davis et al, , 2014.…”

Section: Study Characteristicsmentioning

confidence: 99%

“…Data were collected from participants with intellectual disabilities and asthma in two of the included studies (Davis et al, 2016(Davis et al, , 2014. Data were collected from participants with intellectual disabilities and asthma in two of the included studies (Davis et al, 2016(Davis et al, , 2014.…”

Section: Participantsmentioning

confidence: 99%

“…Some participants reported turning to media platforms, such as YouTube, to find out information regarding their medication (Davis et al, 2016). Some participants reported turning to media platforms, such as YouTube, to find out information regarding their medication (Davis et al, 2016).…”

Section: Format Of Informationmentioning

confidence: 99%

“…and Fish et al (2017) (Beacroft & Dodd, 2010;Davis et al, 2016Davis et al, , 2014Fish et al, 2017;Huneke et al, 2012;Walmsley et al, 2016). and Fish et al (2017) (Beacroft & Dodd, 2010;Davis et al, 2016Davis et al, , 2014Fish et al, 2017;Huneke et al, 2012;Walmsley et al, 2016).…”

Section: Training Health Professionalsmentioning

confidence: 99%

See 2 more Smart Citations

Do people with intellectual disabilities understand their prescription medication? A scoping review

Adams¹,

Carr

Mengoni

2019

Research Intellect Disabil

View full text Add to dashboard Cite

BackgroundPeople with intellectual disabilities are more likely to experience poor health than the general population and are frequently prescribed multiple medications. Therefore, it is important that people with intellectual disabilities understand their medication and potential adverse effects.MethodA scoping review explored people with intellectual disabilities' knowledge of prescription medications, their risks and how medication understanding can be improved.ResultsTen journal articles were included. People with intellectual disabilities often lacked understanding of their medication, including its name, purpose and when and how to take it. Participants were often confused or unaware of adverse effects associated with their medication. Information was sometimes explained to carers rather than people with intellectual disabilities. Some interventions and accessible information helped to improve knowledge in people with intellectual disabilities.ConclusionThere is a need for accessible and tailored information about medication to be discussed with people with intellectual disabilities in order to meet legal and best practice standards.

show abstract

Interdisciplinary medication review to improve pharmacotherapy for patients with intellectual disabilities

Granås

Halvorsen

Wendelbo³

et al. 2019

Int J Clin Pharm

View full text Add to dashboard Cite

Knowledge that people with intellectual disabilities have of their inhaled asthma medications: messages for pharmacists

Cited by 15 publications

References 40 publications

Hospital admissions for respiratory system diseases in adults with intellectual disabilities in Southeast London: a register-based cohort study

Hospital admissions for respiratory system diseases in adults with intellectual disabilities in Southeast London: a register-based cohort study

Do people with intellectual disabilities understand their prescription medication? A scoping review

Interdisciplinary medication review to improve pharmacotherapy for patients with intellectual disabilities

Contact Info

Product

Resources

About